A comprehensive view of Digestive / Gut Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Bayer launches Iberogast in the US, a plant-based digestive relief product developed after more than six decades of research; the proprietary blend is clinically proven to alleviate common digestive symptoms and is available on Amazon and major retailers
Published:
April 24, 2024
by Bayer AG
|
US Patent Issued to Novozymes on April 23 for "Probiotic supplement for metabolic health" (Danish, German, Canadian Inventors)
Published:
April 24, 2024
by U.S. Fed News
|
Mount Sinai researchers identify how a family of proteins activate immune cells related to inflammatory bowel disease; discovery may potentially lead to new treatments for conditions such as ulcerative colitis and Crohn's disease
Published:
April 22, 2024
by Newswise - SciNews
|
FDA approves subcutaneous administration of Takeda’s ENTYVIO (vedolizumab) for maintenance therapy in moderately to severely active Crohn’s Disease
Published:
April 19, 2024
by Business Wire
|
Health Canada approves Merck & Co's KEYTRUDA in combination with chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma treatment following successful Phase 3 trial
Published:
April 19, 2024
by EquityBites
|
Ask us about our Health Care Sector market view